Investors
News Releases
- July 2, 2024Annovis Bio Announces New Data from Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Cognition after Treatment with Buntanetap
- June 27, 2024Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
- June 26, 2024Annovis Bio Files Patent for New Composition of Matter for Buntanetap
Events & Presentations
-
Annovis Bio - Phase III PD Data
-
AD & PD Data Updates - July 2024
Filings
Filings
Description
Date Filed
Available Formats
E-mail Alerts
Back to Top